A blood-pressure drug (e.g., ramipril, lisinopril, enalapril) that also protects the kidneys by reducing protein leakage.
ACE inhibitors lower intraglomerular pressure, reducing albuminuria and slowing CKD progression — benefits independent of blood pressure reduction. They are first-line in diabetic kidney disease and proteinuric CKD. Monitoring includes creatinine (a rise up to 30% is expected and acceptable), potassium (may rise), and cough as a common side effect. Stop during pregnancy and acute illness.
Albumin leaking into urine — the earliest and most important marker of kidney filter damage, measured by urine albumin-to-creatinine ratio (UACR).
Persistently elevated blood pressure - the second leading cause of kidney failure and a driver of CKD progression at every stage.
High potassium in the blood — a common and potentially dangerous complication of CKD, especially with ACEi/ARB therapy — causing heart rhythm disturbances at severe levels.
Kidney damage caused by diabetes - the leading cause of kidney failure worldwide, driven by hyperfiltration, albuminuria, and progressive scarring.
Abnormal presence of protein in the urine, a key marker of kidney damage and the strongest predictor of CKD progression and cardiovascular risk.
Advertisement
ZuvFlo is ready to integrate with your facility to streamline operations, automate compliance, and deliver better patient care.
No credit card required • Setup in under 2 hours • Cancel anytime
Advertisement
This content is a general reference, not medical advice, a diagnosis, or a treatment plan. Do not change your diet, fluids, medicines, or dialysis plan without your nephrologist or renal dietitian. Individual recommendations depend on your labs, medications, conditions, and care plan.